T-cell receptor specific for tetanus toxoid-derived peptides (TT-specific TCR)

The CD4+ T-cell receptor (TCR) specific for tetanus toxoid-derived peptides is a fundamental mediator of the immune response against Clostridium tetani. This receptor, found on the surface of helper T lymphocytes, specifically recognizes antigenic peptides—most notably the universal epitopes p2 and p30—presented by MHC class II molecules, primarily HLA-DR (Source: PubMed, PMID: 2464530). Upon engagement with the peptide-MHC complex, the TCR triggers a signaling cascade involving the CD3 complex and ZAP-70, leading to T-cell activation, proliferation, and the secretion of pro-inflammatory cytokines such as IFN-gamma and IL-2 (Source: Janeway's Immunobiology). This process is essential for the maturation of B cells into antibody-secreting plasma cells that produce neutralizing antitoxin antibodies (Source: StatPearls, Tetanus Toxoid). Because of its high prevalence in the vaccinated population, this TCR is frequently utilized as a positive control in T-cell assays and as a model for studying immunological memory and vaccine efficacy (Source: NIH, NIAID). Therapeutic interventions targeting this receptor primarily include tetanus toxoid vaccines and adjuvants designed to enhance the magnitude and longevity of the T-cell response (Source: CDC, Pink Book).

Other names

Tetanus toxoid-specific T-cell receptorTT-TCRCD4+ T-cell receptor (tetanus toxoid)Tetanus toxoid-reactive TCR

The T-cell receptor (TCR) recognizes specific tetanus toxoid peptides presented by MHC class II molecules on antigen-presenting cells, triggering a signaling cascade that leads to CD4+ T-cell proliferation, cytokine secretion, and B-cell help for antibody production.